Infection in solid-organ transplant recipients.

  title={Infection in solid-organ transplant recipients.},
  author={Jay A. Fishman},
  journal={The New England journal of medicine},
  volume={357 25},
  • J. Fishman
  • Published 20 December 2007
  • Medicine, Biology
  • The New England journal of medicine
The risk of infection after transplantation changes over time, particularly with modifications in immunosuppression. Unfortunately, no assays accurately measure a patient’s risk of infection. Currently, therefore, the clinician assesses a recipient’s risk of infection while considering the risk of allograft rejection, the intensity of immunosuppression, and other factors that may contribute to his or her susceptibility to infection. Prophylactic strategies are based on the patient’s known or… 

Figures and Tables from this paper

Risk and Epidemiology of Infections After Solid Organ Transplantation

Transplant recipients are uniquely susceptible to infectious diseases due to the nature of their underlying conditions and their immunosuppressed status; consequently infections in solid organ

Infections in pediatric solid organ transplant recipients

An overview of the risk factors, timing, and types of infectious complications associated with organ transplantation in children is provided.

Risk Assessment of Infections in SOT Recipients

The susceptibility to infection among solid organ transplant (SOT) recipients is modulated by a number of pre- and post-transplant variables that must be taken into account in the risk assessment

Common infections in kidney transplant recipients.

Common post-transplant infections are reviewed, including prophylactic, diagnostic, and treatment strategies, providing guidance regarding care of kidney transplant patients with infection.

Infections in the Adult Solid Organ Transplant Recipient

This chapter reviews common and serious infections seen in solid organ transplant recipients, including approaches to the initial infectious workup for patients presenting with diarrhea, respiratory infections, urinary tract infections, central nervous system infections, and skin and soft tissue infections.

Infection in Organ Transplantation

  • J. Fishman
  • Medicine, Biology
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2017
Transplant infectious disease remains a key to the clinical and scientific investigation of organ transplantation and application of quantitative molecular microbial assays and advanced antimicrobial therapies have advanced care.

Infection in Kidney Transplantation

Infection is an important cause of morbidity and mortality after kidney transplantation and awareness of the approach to infection in the transplant recipient including diagnostic and management strategies is essential to optimizing outcomes.

Fungal Infections in Solid Organ Transplant Recipients

Fungal infections in organ transplant recipients (OTRs) vary in frequency, etiology, and pathogenesis according to the type of organ transplant procedure, and variations in immunosuppressive regimens, surgical technique, infection control, and exposure history further complicate evaluation of these patients.

Infection in solid-organ transplant recipients.

To the Editor: In his review of infections in recipients of solid-organ transplants, Fishman (Dec. 20 issue)1 discusses Clostridium difficile diarrhea in the immediate post-transplantation period.

Post Kidney Transplant: Infectious Complication

Throughout this chapter multiple drug therapies will be reviewed, however in the setting of opportunistic infection, the key to mitigation is allowance of host immune reconstitution.



Infection in the renal transplant recipient.

Fungal infections in the recipients of solid organ transplantation.

  • N. Singh
  • Medicine, Biology
    Infectious disease clinics of North America
  • 2003

Impact of donor infections on outcome of orthotopic liver transplantation

  • M. AngelisJ. CooperR. Freeman
  • Medicine, Biology
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2003
Assessment of the risk of transmission of bacterial, fungal, viral, and parasitic infectious agents from cadaveric liver donors to recipients and the effect such a transmission has on liver function, morbidity, and mortality is focused on.

BK virus nephropathy--polyomavirus adding insult to injury.

  • J. Fishman
  • Biology, Medicine
    The New England journal of medicine
  • 2002
The problem of viral infections in transplantation reflects the intricate balance between lifelong viral infection in tissues, the host's antiviral immune function, and the level of immunosuppression required to maintain graft function.

Review of solid-organ transplantation in HIV-infected patients

Increasing numbers of HIV-infected patients with end-stage organ disease are potential candidates for transplantation, and encouraging preliminary data are increasingly available in the HAART era.

The challenges of infection in transplantation: donor-derived infections

Investigation of donor-derived infections requires suspicion on the part of caregivers, utilization of newer diagnostic tools, and coordination of epidemiologic investigations between medical centers and public health authorities.

The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients.

  • L. Munoz-PriceM. Slifkin D. Snydman
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2004
Use of prophylactic ganciclovir is independently associated with a significant reduction of bacteremia in OLT recipients.

Liver transplantation in patients with HIV infection

Key Points 1 Liver transplantation for human immunodeficiency virus (HIV)‐positive patients with end‐stage liver disease in the era of highly active retroviral therapy has proven to be an effective

Prevention of Infection Due to Pneumocystis spp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients

The risk for PCP varies based on individual immune defects, regional differences, and immunosuppressive regimens, and the agent of choice for prophylaxis against Pneumocystis unless a clear contraindication is identified.

Cytomegalovirus and Lung Transplantation

  • M. Zamora
  • Medicine, Biology
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2004
Cytomegalovirus (CMV) infection remains a serious problem in lung transplant recipients. Development of potent oral antiviral agents, molecular techniques for the detection of infection and its